Alex’s Lemonade Stand Foundation Crazy 8 Initiative

The Alex’s Lemonade Stand Foundation (ALSF) Crazy 8 Initiative award programme was launched in 2018 to support research into innovative and rigorous approaches that directly address the most intractable issues in paediatric cancer research today. The award is designed to coalesce cross-disciplinary cores of scientists working collaboratively in order to accelerate the pace of new cure discovery.

Investigations may involve the exploration of a novel scientific hypothesis or the development of new model systems, tools or technologies that have the potential for significant impact on the field of childhood cancer. Collaboration and resource sharing are a priority for this research programme. ALSF expects successful applications to propose multidisciplinary teams with a very clear plan for collaboration that would empower the study of big ideas, which would not be easily addressable otherwise.

The proposal should address a topic that is responsive to at least one of the following paediatric cancer research themes:

Developmental Origins of Paediatric Cancers.

Drugging Currently Undruggable Paediatric Cancer Drivers.

Developing Novel Immunotherapies.

Discovery and Development of Novel Paediatric Cancer Drug Targets.

Applicant institutions may be based in the United States or abroad, and applicants need not be United States citizens. Funds must be granted to non-profit institutions or organisations.

Depending on the type of project and the size of the team, the requested budget should be in the range of $3-5 million over four years.

A Letter of Intent must be submitted by the deadline of 26 April 2021.

More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.